1989
DOI: 10.1016/0020-7292(89)90237-3
|View full text |Cite
|
Sign up to set email alerts
|

Peritoneal fluid cytology and prognosis in patients with endometrial carcinoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
2
0
2

Year Published

1990
1990
2008
2008

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 13 publications
(4 citation statements)
references
References 0 publications
0
2
0
2
Order By: Relevance
“…The efficacy of these modalities for treating positive cytology in the absence of other evidence of extrauterine disease is not universally accepted (McLellan et al, 1989;Lurain, 1992). On the other hand, investigators who did not find that malignant peritoneal cytology is a significant prognostic factor found no benefit of adjuvant therapy in patients with positive cytology in the absence of other adverse prognostic factors (Yazigi et al, 1983; Peritoneal cytology in endometrial carcinoma T Kasamatsu et al Hernandez et al, 1985;Konski et al, 1988;Hirai et al, 1989;Lurain et al, 1989;Grimshaw et al, 1990;Kadar et al, 1992;Kennedy et al, 1993;Ayhan et al, 1994;Ebina et al, 1997;Yalman et al, 2000). This discrepancy is probably because of the following: (1) the reported incidence of positive cytology was approximately 10% and the number of subjects was small; (2) the difference between the surgical stage and the clinical stage was not always distinguished; (3) various modalities of preoperative and/or postoperative therapies were used; (4) in the statistical analysis, multivariate analysis was not always employed; (5) the objectivity of the cytopathologic diagnosis was not always guaranteed; and (6) a prospective study has not been performed.…”
Section: Discussionmentioning
confidence: 99%
“…The efficacy of these modalities for treating positive cytology in the absence of other evidence of extrauterine disease is not universally accepted (McLellan et al, 1989;Lurain, 1992). On the other hand, investigators who did not find that malignant peritoneal cytology is a significant prognostic factor found no benefit of adjuvant therapy in patients with positive cytology in the absence of other adverse prognostic factors (Yazigi et al, 1983; Peritoneal cytology in endometrial carcinoma T Kasamatsu et al Hernandez et al, 1985;Konski et al, 1988;Hirai et al, 1989;Lurain et al, 1989;Grimshaw et al, 1990;Kadar et al, 1992;Kennedy et al, 1993;Ayhan et al, 1994;Ebina et al, 1997;Yalman et al, 2000). This discrepancy is probably because of the following: (1) the reported incidence of positive cytology was approximately 10% and the number of subjects was small; (2) the difference between the surgical stage and the clinical stage was not always distinguished; (3) various modalities of preoperative and/or postoperative therapies were used; (4) in the statistical analysis, multivariate analysis was not always employed; (5) the objectivity of the cytopathologic diagnosis was not always guaranteed; and (6) a prospective study has not been performed.…”
Section: Discussionmentioning
confidence: 99%
“…endometrioid adenocarcinoma confined to the uterus. Before incorporating peritoneal cytology into the new staging system in 1988, the incidence of positive cytology in stage I endometrioid adenocarcinoma was reported to range from 15 to 35% [3,12] while it dropped to 5 to 10% in the literature of the last 15 years [4,8]. In our study, we found 8.7% peritoneal cytology positivity in patients with.…”
Section: Discussionmentioning
confidence: 72%
“…O carreamento de células neoplásicas para a cavidade peritonial é uma possibilidade, e a literatura é controversa quanto ao prognóstico destas pacientes, com relatos mostrando não haver diferenças nas taxas de recorrência e sobrevivência nas pacientes que tiveram ou não células malignas detectadas na cavidade peritonial 16,17 , e outros mostrando poder haver piora no prognóstico 18,19 . A injeção lenta e sob baixa pressão deve ser utilizada para prevenir o extravasamento do contraste, e nos casos suspeitos de neoplasia é recomendado o uso de água destilada para causar lise osmótica das células desgarradas com o procedimento, evitando-se assim a possibilidade de disseminação da doença 12,20 .…”
Section: Discussionunclassified